Fig. 2

Erythropoietin enhances neuronal differentiation in female NCSCs. A: Schematic summary of neuronal differentiation with EPO treatment (1 U/ml) for six weeks. B: Immunocytochemistry revealed a homogenous expression of vGlut-II. On the other hand, expression of NF200 and MAP-2 is slightly increased in NCSCs derived from female donors. White arrows depict MAP2 positiv axons. C, D : Camera Lucida Tracing reveals elongated axons of female NCSCs upon EPO supplementation. (Mann-Whitney test, *p < 0.05, **p < 0.01, ***p < 0.001. was considered significant